Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | TP53 | P04637 | 3/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 3/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27085680 | 1.00 | TSHR (0.46) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL1537033 | 1.00 | TSHR (0.46) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL347405 | 1.00 | TSHR (0.46) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL44451 | 1.00 | TSHR (0.46) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL1536968 | 1.00 | TSHR (0.46) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL2462848 | 1.00 | TSHR (0.46) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL2988873 | 1.00 | TSHR (0.46) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL1536995 | 1.00 | TSHR (0.46) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL1286343 | 1.00 | TSHR (0.46) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL1536868 | 1.00 | TSHR (0.46) | TSHRALDH1A1TP53HIF1ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 706 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3573461-B1 | ANTIMICROBIAL, NON-THROMBOGENIC POLYMER COMPOSITIONS | LUBRIZOL ADVANCED MAT INC (US) | 2026-04-22 | — | — | EP | claimed |
| US-12528966-B2 | Coatings | P2I LTD (GB) | 2026-01-20 | — | — | US | claimed |
| WO-2025103301-A1 | COATING AND PREPARATION METHOD THEREFOR | 江苏菲沃泰纳米科技股份有限公司 | 2025-05-22 | — | — | WO | claimed |
| EP-3307835-B2 | COATINGS | P2I LTD (GB) | 2025-04-02 | — | — | EP | claimed |
| US-20240429448-A1 | Silicon-Based Energy Storage Devices With Carboxylic Ether, Carboxylic Acid Based Salt, or Acrylate Electrolyte Containing Electrolyte Additives | ENEVATE CORP (US) | 2024-12-26 | — | — | US | claimed |
| US-11879024-B1 | Soft mold formulations for surface relief grating fabrication with imprinting lithography | META PLATFORMS TECHNOLOGIES, LLC (US) | 2024-01-23 | — | — | US | claimed |
| CN-109071966-B | Coating layer | P2I有限公司 | 2022-07-22 | — | — | CN | claimed |
| US-20220145037-A1 | METHODS OF PREPARATION OF OMNIPHOBIC SURFACES | NUTECH VENTURES (US) | 2022-05-12 | — | — | US | claimed |
| US-11318226-B2 | Materials for preparing intraocular lens | EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD. (CN) | 2022-05-03 | — | — | US | claimed |
| EP-3361868-B1 | BIOCIDALLY ACTIVE POLYMER COMPOSITIONS | LUBRIZOL ADVANCED MAT INC (US) | 2021-12-15 | — | — | EP | claimed |
| US-20140194547-A1 | SURFACE MODIFICATION METHOD AND SURFACE-MODIFIED ELASTIC BODY | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2014-07-10 | — | — | US | claimed |
| EP-2752436-A1 | Surface modification method and surface-modified elastic body | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2014-07-09 | — | — | EP | claimed |
| US-20140128493-A1 | SURFACE-MODIFYING METHOD AND ELASTIC BODY WITH MODIFIED SURFACE | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2014-05-08 | — | — | US | claimed |
| US-20130310772-A1 | SURFACE MODIFICATION METHOD AND SURFACE-MODIFIED ELASTIC BODY | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2013-11-21 | — | — | US | claimed |
| US-20130274367-A1 | SURFACE MODIFICATION METHOD, SURFACE-MODIFIED ELASTIC BODY, GASKET FOR INJECTOR, INJECTOR, AND TIRE | KYUSHU UNIVERSITY (JP) | 2013-10-17 | — | — | US | claimed |
| US-20100055463-A1 | HYDROPHOBIC CARBON BLACK INTERMEDIATE TRANSFER COMPONENTS | XEROX CORPORATION (US) | 2010-03-04 | — | — | US | claimed |
| WO-2009082833-A1 | FUNCTIONAL FLUORIDE ANTI-BLEED AGENTS WITH REACTIVE GROUPS AN APPLICATION IN ORGANIC BASED CURABLE COMPOSITIONS | HENKEL AG & CO. KGAA (DE) | 2009-07-09 | — | — | WO | claimed |
| US-20030194378-A1 | Novel aerosol formulation containing a polar fluorinated molecule | ASTRAZENECA AB (SE) | 2003-10-16 | — | — | US | claimed |
| EP-1303258-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | AstraZeneca AB (SE) | 2003-04-23 | — | — | EP | claimed |
| WO-2002003958-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2002-01-17 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12528966-B2 | Coatings | C9, SDC1, CD59 | TSHR 3218/4885ALDH1A1 1446/4885TP53 4726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.